These observations point to the potential of CKM as a complementary strategy to immune checkpoint inhibitors, as CKM results in infiltration of CD8+T cells into the tumor and immune checkpoint inhibitors could reverse the exhaustion signature on these CD8+T cells. The gene discussed is CKM; the disease is neoplasm.